Never mind the January 2019 hikes…Pharma sill puts pricing at the top of its worry list
April 06, 2019 Slightly more than half of respondents to a GlobalData survey tagged pricing and reimbursement as their biggest worry this year, the analytics firm said. As that pricing pressure rolls on, GlobalData analysts also expect “aggressive negotiation tactics to drive down drug prices.” The survey results come as the biopharma industry flocked to … Read more